Health Care & Life Sciences » Biotechnology | Loxo Oncology Inc.

Loxo Oncology Inc.

Loxo Oncology Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
30.47 M
Public Float
21.8 M
Loxo Oncology Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.65
Market Cap
$5.2 B
Shares Outstanding
30.47 M
Public Float
27.26 M

Profile

Address
281 Tresser Boulevard
Stamford Connecticut 06901
United States
Employees -
Website http://www.loxooncology.com
Updated 09/14/2018
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H.

Financials

View All
Created with Highcharts 5.0.14Loxo Oncology Inc.Net Income. Fiscal year is January-December. All values USD Thousands.10 30210 30220 67220 67235 87635 87672 39872 398148 876148 87620132014201520162017025k50k75k100k125k150k175k
Created with Highcharts 5.0.14Loxo Oncology Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0000000021 30021 3002013201420152016201705k10k15k20k25k

Joshua H. Bilenker
President, Chief Executive Officer & Director
Keith T. Flaherty
Director